salvinorin a has been researched along with Anxiety in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butelman, ER; Ewald, A; Kivell, BM; Kornberger, L; McElroy, BD; Prisinzano, TE; van de Wetering, R; Welsh, S; Williamson, SE | 1 |
| Biggerstaff, A; Crowley, RS; Culverhouse, A; Kivell, BM; Kumar, N; Morani, AS; Paton, KF; Prisinzano, TE; Shepherd, A; Welsh, SA | 1 |
2 other study(ies) available for salvinorin a and Anxiety
| Article | Year |
|---|---|
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.
Topics: Animals; Anxiety; Cocaine; HEK293 Cells; Humans; Locomotion; Mice; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward | 2023 |
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.
Topics: Animals; Anxiety; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Diterpenes; Diterpenes, Clerodane; Learning; Male; Mesylates; Mice; Motor Activity; Nociception; Pain; Rats; Receptors, Opioid, kappa; Recognition, Psychology | 2018 |